Healthcare -
Biotechnology - NASDAQ - FR
$ 1.69
1.2 %
$ 142 M
Market Cap
-3.93
P/E
IPHA - REVENUE
Revenue IPHA - Innate Pharma S.A.
51.9 M
LAST VALUE
107.00%
2 YEAR CAGR
-8.27%
5 YEAR CAGR
15.33%
10 YEAR CAGR